MassMutual Private Wealth & Trust FSB Has $24.09 Million Stake in Stryker Corporation $SYK

MassMutual Private Wealth & Trust FSB decreased its stake in shares of Stryker Corporation (NYSE:SYK) by 5.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 68,553 shares of the medical technology company’s stock after selling 4,322 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Stryker were worth $24,094,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in SYK. Brighton Jones LLC grew its position in Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares in the last quarter. Schnieders Capital Management LLC. acquired a new position in Stryker in the 2nd quarter valued at approximately $205,000. Intech Investment Management LLC lifted its position in shares of Stryker by 8.7% in the 2nd quarter. Intech Investment Management LLC now owns 5,977 shares of the medical technology company’s stock worth $2,365,000 after acquiring an additional 477 shares during the period. Empowered Funds LLC lifted its position in shares of Stryker by 43.9% in the 2nd quarter. Empowered Funds LLC now owns 12,491 shares of the medical technology company’s stock worth $4,942,000 after acquiring an additional 3,813 shares during the period. Finally, Catalyst Funds Management Pty Ltd acquired a new stake in shares of Stryker during the 2nd quarter worth approximately $475,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Needham & Company LLC upped their target price on Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Citigroup reiterated a “market outperform” rating on shares of Stryker in a research note on Friday, January 30th. The Goldman Sachs Group set a $399.00 price target on shares of Stryker in a report on Friday, January 9th. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, Robert W. Baird set a $437.00 price objective on shares of Stryker in a report on Friday, January 30th. Fourteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 5.90% of the company’s stock.

Stryker Trading Down 1.1%

Shares of SYK opened at $335.96 on Friday. Stryker Corporation has a 1 year low of $328.23 and a 1 year high of $404.87. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The stock has a 50 day simple moving average of $363.25 and a 200-day simple moving average of $366.04. The stock has a market cap of $128.57 billion, a PE ratio of 39.99, a PEG ratio of 1.99 and a beta of 0.85.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping the consensus estimate of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter last year, the company earned $4.01 EPS. Stryker’s revenue was up 11.4% on a year-over-year basis. On average, sell-side analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. Stryker’s dividend payout ratio (DPR) is presently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.